SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-21-282412
Filing Date
2021-09-24
Accepted
2021-09-24 16:41:05
Documents
17
Period of Report
2021-08-26
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d207285d8ka.htm   iXBRL 8-K/A 30695
2 EX-23.1 d207285dex231.htm EX-23.1 2323
3 EX-99.1 d207285dex991.htm EX-99.1 330908
4 EX-99.2 d207285dex992.htm EX-99.2 291270
5 EX-99.3 d207285dex993.htm EX-99.3 241087
  Complete submission text file 0001193125-21-282412.txt   1184964

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA aadi-20210826.xsd EX-101.SCH 2750
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aadi-20210826_def.xml EX-101.DEF 14282
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE aadi-20210826_lab.xml EX-101.LAB 24066
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aadi-20210826_pre.xml EX-101.PRE 15250
10 EXTRACTED XBRL INSTANCE DOCUMENT d207285d8ka_htm.xml XML 6960
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38560 | Film No.: 211277877
SIC: 2834 Pharmaceutical Preparations